Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant in recurrent ovarian carcinoma
NCT00617188Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in ovarian cancer, sponsored by Masonic Cancer Center. Started Jun 2007; status: completed.
02
Drugs
fulvestrant
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00617188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617188.